Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.41% | 202.72 | 1.3% | $426.59m | |
| BIIB | Biogen Inc. | -2.46% | 220.06 | 1.3% | $391.11m | |
| GILD | Gilead Sciences, Inc. | -0.49% | 64.91 | 0.9% | $378.65m | |
| CELG | Celgene Corporation | 1.13% | 102.95 | 1.3% | $367.47m | |
| ILMN | Illumina, Inc. | -0.36% | 309.44 | 3.5% | $247.45m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.46% | 300.19 | 2.6% | $218.58m | |
| EXAS | Exact Sciences Corporation | -0.95% | 96.47 | 24.1% | $199.33m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.84% | 176.23 | 1.9% | $176.44m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.58% | 98.41 | 2.0% | $169.95m | |
| A | Agilent Technologies, Inc. | -0.44% | 74.59 | 1.6% | $143.57m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.91% | 85.77 | 14.6% | $132.47m | |
| BMRN | BioMarin Pharmaceutical Inc. | 1.84% | 69.15 | 4.3% | $96.30m | |
| SGEN | Seattle Genetics, Inc. | 1.70% | 87.40 | 6.2% | $95.18m | |
| NKTR | Nektar Therapeutics | -2.81% | 17.27 | 5.5% | $84.77m | |
| ALDR | Alder Biopharmaceuticals, Inc. | 0.11% | 18.92 | 10.2% | $81.63m |
Company Profile
Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the development and discovery of novel vaccines and immuno-oncology therapeutics. It focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.